{"id":"W2021770899","doi":"10.1016/j.clgc.2014.11.001","title":"First-Line and Sequential Use of Pazopanib Followed by Mammalian Target of Rapamycin Inhibitor Therapy Among Patients With Advanced Renal Cell Carcinoma in a US Community Oncology Setting","year":2014,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Canadian Centre for Applied Research in Cancer Control; GlaxoSmithKline","keywords":"Pazopanib; Medicine; Temsirolimus; Everolimus; Internal medicine; Oncology; Adverse effect; Renal cell carcinoma; Cohort; Nausea; Clinical trial; Sunitinib; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006478176,0.0003237322,0.001042092,0.0001191947,0.00008423901,0.00000761958,0.0001483024,0.0002581188,0.000049219],"category_scores_gemma":[0.000142088,0.0002511272,0.0001855234,0.0002066183,0.0004422744,0.0001311403,0.0001387075,0.0007032632,8.057058e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001951916,"about_ca_system_score_gemma":0.0002141083,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001263578,"about_ca_topic_score_gemma":0.0004339958,"domain_scores_codex":[0.9968322,0.0008953365,0.001140182,0.0004275694,0.000332263,0.0003724427],"domain_scores_gemma":[0.9974535,0.0008385017,0.0006438521,0.000551782,0.0002398505,0.0002725199],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007137659,0.002542272,0.9775511,0.0002102256,0.00008695455,0.00006971582,0.0002916121,0.0003145976,0.005080335,2.367328e-7,0.0003560486,0.006359227],"study_design_scores_gemma":[0.01932875,0.0153264,0.9329115,0.0002217022,0.0001350845,0.000004928385,0.00005943341,0.0002210902,0.03024331,0.000007189405,0.001316435,0.0002241832],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977513,0.0005977032,0.00002481336,0.0001486024,0.0001957082,0.001023585,0.0001180291,0.00001686865,0.0001233975],"genre_scores_gemma":[0.9970628,0.0002308227,0.001966844,0.0001959315,0.000166451,0.00008402896,0.0001548288,0.00005225822,0.00008601279],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04463962,"threshold_uncertainty_score":0.9999941,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04026818035067124,"score_gpt":0.3145901358223183,"score_spread":0.274321955471647,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}